FOLH1 and prostate cancer: To optimize the labeling of PSMA-HBED-CC with99mTc-pertechnetate for prostate cancer imaging, the labeling procedure should be carried out at 100°C for 15 minutes using 3 μg of SnCl2, minimizing the presence of free99mTc-pertechnetate and colloid formation.